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PURPOSE. Several reports have shown that mutations in the ABCR gene can lead to Stargardt disease
(STGD)/fundus flavimaculatus (FFM), autosomal recessive retinitis pigmentosa (arRP), and autoso-
mal recessive cone-rod dystrophy (arCRD). To assess the involvement of ABCR in these retinal
dystrophies, the gene was screened in a panel of 70 patients of British origin.
METHODS. Fifty-six patients exhibiting the STGD/FFM phenotype, 6 with arRP, and 8 with arCRD,
were screened for mutations in the 50 exons of the ABCR gene by heteroduplex analysis and direct
sequencing. Microsatellite marker haplotyping was used to determine ancestry.
RESULTS. In the 70 patients analyzed, 31 sequence changes were identified, of which 20 were
considered to be novel mutations, in a variety of phenotypes. An identical haplotype was associated
with the same pair of in-cis alterations in 5 seemingly unrelated patients and their affected siblings
with STGD/FFM. Four of the aforementioned patients were found to carry three alterations in the
coding sequence of the ABCR gene, with two of them being in-cis.
CONCLUSIONS. These results suggest that ABCR is a relatively polymorphic gene. Because putative
mutations have been identified thus far only in 25 of 70 patients, of whom only 8 are compound
heterozygotes, a large number of mutations have yet to be ascertained. The disease haplotype seen
in the 5 patients carrying the same “complex” allele is consistent with the presence of a common
ancestor. (Invest Ophthalmol Vis Sci. 2000;41:16–19)
Stargardt disease (STGD; MIM No. 248200) is the mostfrequent cause of inherited macular dystrophy in child-hood, with an estimated prevalence of 1:10,000.1 Fundus
flavimaculatus (FFM) presents with a similar phenotype to
STGD, and linkage analysis suggests that the two are allelic
autosomal recessive conditions mapping to the short arm of
chromosome 1 (1p21–p22.1).2,3 Homozygosity mapping has
demonstrated additional loci for autosomal recessive retinitis
pigmentosa (arRP) and autosomal recessive cone-rod dystro-
phy (arCRD), which colocalize with the STGD/FFM locus.4,5
More recently, the ABCR gene, which encodes a retina-specific
ATP-binding cassette (ABC) transporter, has also been mapped
to the same chromosomal location.6,7 Mutations in the ABCR
gene have now been implicated in all the above conditions.
Previous studies have demonstrated ABCR mutations in
30% to 50% of the STGD/FFM patients screened.7–9 Of these, a
lesser percentage has been shown to carry mutations on both
alleles of the gene.8 We set out to determine the mutation
spectrum of the ABCR gene in recessive retinal dystrophies by
screening all 50 exons of the gene in 70 unrelated British
patients with a STGD/FFM, arRP, or arCRD phenotype.
METHODS
Ascertainment of Patients
Patients were from small nuclear families showing a recessive
mode of inheritance of disease, with both parents being unaf-
fected. Patients were British residents of a variety of ethnic
origins (European Caucasian, and Asian from the Indian sub-
continent). All 70 patients were identified through the retinal
dystrophy clinics at Moorfields Eye Hospital using standard
techniques and were clinically categorized into three groups:
(1) patients with a diagnosis of Stargardt disease/fundus flavi-
maculatus (n 5 56) based on macular dysfunction on pattern
electroretinogram (ERG) and the presence of orange/yellow
flecks at the posterior pole, sometimes extending anterior to
the vascular arcades; (2) one affected member of each of six
families with arRP, with the diagnosis based on typical periph-
eral pigmentary retinal degeneration and markedly reduced
scotopic ERG; and (3) one affected member of each of eight
families with arCRD, with the diagnosis based on the finding of
abnormal cone (30-Hz flicker) and rod (scotopic) ERGs and the
absence of retinal flecks. For the arRP and arCRD families, all
affected siblings showed identical haplotypes for the microsat-
ellite markers tested from the 1p21–p22.1 region, thus provid-
ing evidence in support of linkage to the STGD/FFM locus (data
not shown). Informed consent for genetic studies in adherence
to the Declaration of Helsinki was obtained by the examining
clinicians. For comparison, 96 ethnically matched individuals
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with no personal or family history of retinopathy were selected
to serve as controls.
Heteroduplex and Haplotype Analyses
Genomic DNA was extracted using the Nucleon II extraction
kit (Scotlab Bioscience) and amplified using primers that al-
lowed amplification of the complete coding region (50 exons)
under standard conditions.6,10 Amplified exons were analyzed
by electrophoresis on MDE Flowgen gels run at 180 V over-
night using Hoeffer 600S apparatus. Microsatellite markers
described in Table 3 were used for genotyping with polymer-
ase chain reaction (PCR). Amplified products were fractionated
on 8% nondenaturing polyacrylamide gels and visualized by
ethidium bromide staining.
Direct Sequencing
PCR products that demonstrated a heteroduplex pattern were
sequenced using the PRISM Ready Reaction Sequencing Kit
(Perkin–Elmer Cetus) and analyzed on an ABI 373 automated
sequencer.
RESULTS
A total of 20 novel sequence changes were identified and
thought to be mutations in 20 of 56 STGD/FFM, 1 of 6 arRP,
and 4 of 8 arCRD patients. The majority of the mutations were
single nucleotide substitutions at conserved amino acid posi-
tions, but deletion events were also observed (Table 1). It is
notable that the four truncating mutations (at amino acid po-
sitions Cys779, Leu1147, Tyr1779, and Arg2030) were identi-
fied in three patients with STGD/FFM and one with arCRD.
Only eight patients were found to be compound heterozy-
gotes, whereas the majority were heterozygous for a single
mutation (13 STGD/FFM, 1 arRP, and 3 arCD). Although none
of these changes was detected in 96 control samples, their
pathogenicity has yet to be determined either biochemically or
using animal models. Twenty-eight patients had at least one
sequence variant identified as a “polymorphism,” whereas 14
patients had more than 2 (Table 2). Interestingly, most of these
polymorphisms appear to concentrate toward the 39-end of the
gene, namely in exon 42, and introns 43, 48, and 49. By
contrast, the observed mutations are distributed evenly
throughout the entire coding sequence of the ABCR gene, and
the phenomenon of clustering within specific regions such as
the ATP-binding domains was not detected.
In the family of a STGD/FFM patient, three sequence
alterations Cys-54-Tyr, Gly-863-Ala, and Arg-943-Gln in ABCR
exons 3, 17, and 19, respectively, were found to be present.
Both the Gly-863-Ala and Arg-943-Gln substitutions were
present in the unaffected mother who had no clinical evidence
of the disease at the age of 58 years. Neither of these putative
TABLE 1. List of Mutations Found in 70 Patients of British Origin
Nucleotide Change Amino Acid Change No. of Patients (/70) Phenotype
No. of
Controls (/96)
G161A Cys-54-Tyr 1 STG/FFM NF
A286G Asn-96-Asp 1 STG/FFM NF
A286C Asn-96-His 1 STG/FFM NF
A466G Ile-156-Val 1 STG/FFM NF
C1220T Ala-407-Val 6 STG/FFM, arCRD NF
T1271C Val-424-Ala 2 STG/FFM, arRP NF
C1335G Ser-445-Arg 1 STG/FFM NF
C1804T Arg-602-Trp 1 STG/FFM NF
C2337A Cys-779-Ter 1 STG/FFM NF
*G2588C Gly-863-Ala 5 STG/FFM 2/176
3392delC 1147 Ter 1 STG/FFM NF
T4286C Val-1429-Ala 1 STG/FFM NF
4774-2A3C Splice acceptor 2 STG/FFM NF
†C4918T Arg-1640-Trp 1 STG/FFM NF
C5107G Gln-1703-Lys 1 STG/FFM NF
5161delAC Frameshift 1 STG/FFM NF
C5337G Tyr-1779-Ter 1 STG/FFM NF
C6088T Arg-2030-Ter 1 arCRD NF
628217G3A Splice donor 1 STG/FFM NF
G6449A Cys-2150-Tyr 2 arCRD NF
A6479G Lys-2160-Arg 1 STG/FFM NF
* Independently reported by Allikmets et al.6
† Independently reported by Rozet et al.8
NF, not found in 96 ethnically matched control individuals.
TABLE 2. List of Polymorphisms Found in 70 Patients of British
Origin
Nucleotide
Change Exon
Amino Acid
Change
No. of
Patients
(/70)
No. of
Controls
(/96)
1356111delG 10 intron — 2 NF
*G2828A 19 Arg-943-Gln 8 16/176
3815-82G3C 25 intron — 1 NF
G5682C 40 Leu-1894-Leu 1 30
C5842T 42 Pro-1948-Leu 4 7
G5844A 42 Pro-1948-Pro 12 22
T5885C 42 Val-1962-Val 9 NF
6006-16G3A 43 intron — 19 NF
6729121C3T 48 intron — 2 NF
6816127G3C 49 intron — 4 NF
* Independently reported by Allikmets et al.6
NF, not found.
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mutations was detected in the unaffected father, in whom the
third alteration (Cys-54-Tyr) was identified. All three alterations
were present in the three affected siblings but not in the
unaffected ones. We therefore assumed that the two sequence
changes Gly-863-Ala and Arg-943-Gln were in-cis on the mater-
nally inherited chromosome, comprising a “complex” allele.
Moreover, because the mother and the unaffected siblings
reported no symptoms of the disease, these two changes on
their own were not enough to produce the STGD/FFM pheno-
type when found in-cis.
When screening additional patients, we discovered that
four more individuals affected with STGD/FFM carried the
same two changes in-cis (Gly-863-Ala and Arg-943-Gln). Haplo-
type analysis by means of eight microsatellite markers, distrib-
uted over a 63-cM interval around the ABCR locus, revealed
conservation of alleles between these five families, with af-
fected individuals sharing at least five of them (Table 3). In
addition, three of these affected individuals also carried a third
sequence variation (Asn-96-His, Ala-407-Val, or Val-424-Ala) de-
rived from the other parental chromosome. A third mutation
on the other parental chromosome has not been detected in
the fourth individual so far.
DISCUSSION
This study has demonstrated mutations in 45% of the STGD/
FFM patients, with only 14% being compound heterozygotes;
therefore, a great number of mutations have yet to be ascer-
tained. The detection of ABCR changes in our patients is
comparable with that of other studies, and it is possible that
allelic mutations reside in parts of the gene (e.g., the promoter
region or the introns) that have not yet been screened. Because
no sequence changes in this gene have been investigated for
deleterious effects to protein function or RNA splicing, some of
the variants classified as polymorphisms could represent mu-
tations. For example, although an exonic sequence alteration
might not introduce an amino acid substitution, it may intro-
duce an ectopic splice site and thus have a detrimental effect
on RNA splicing. Similarly, it can be speculated that an intronic
sequence change could also affect proper splicing even if it
occurs outside the splice consensus sequences.11
Microheterogeneity in this region of chromosome 1 with
a second as yet unidentified gene lying in the vicinity of the
ABCR gene could explain the lack of observed mutations in 5
of 6 and 4 of 8 of the arRP and arCRD families, respectively,
that are linked to this locus. A similar occurrence of heteroge-
neity has been noticed in other disorders where mutational
screening has excluded candidate genes from linked families.12
In general, there is a limited number of reports demon-
strating founder effects in human genetic disorders. Here we
report such a phenomenon in the ABCR gene, even though it
accounts for a small proportion (9%) of the STGD/FFM patients
investigated. The allele in question is the “complex” one car-
rying two sequence changes, Gly-863-Ala and Arg-943-Gln, in-
cis. The absence of the disease haplotype in 50 control samples
tested is consistent with the presence of a founder effect in the
5 patients and their families.
In this study, 7% of the STGD/FFM patients were found to
carry three sequence variations in the ABCR gene. Of the two
amino acid alterations in-cis, Gly-863-Ala besides being a puta-
tive missense mutation could also affect proper RNA splicing as
it occurs at the acceptor splice site of exon 17.13 The second
alteration, Arg-943-Gln, has been classified as a “polymor-
phism.”6 It could be that both changes contribute to the
disease phenotype, having an additive effect as has been re-
ported in other diseases.14 The ABCR gene and its protein have
only recently been characterized; however, another “relative”
from the ABC family, the CFTR gene, has been more thor-
oughly investigated. In the case of the CFTR gene and cystic
fibrosis (CF), “complex” alleles appear to be relatively frequent
and modulate the phenotype of CF patients.13 Further bio-
chemical and/or animal model studies are needed to establish
the effect of single and multiple sequence changes in the ABCR
protein.
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11.9
D1S2813 1 1 1 1 1 1 1 1 1 1
ABCR gene 2.9
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